Singapore markets closed
  • Straits Times Index

    3,173.91
    +9.05 (+0.29%)
     
  • Nikkei

    29,068.63
    +517.70 (+1.81%)
     
  • Hang Seng

    25,330.96
    +368.37 (+1.48%)
     
  • FTSE 100

    7,234.03
    +26.32 (+0.37%)
     
  • BTC-USD

    61,660.59
    +2,565.62 (+4.34%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • Dow

    35,294.76
    +382.20 (+1.09%)
     
  • Nasdaq

    14,897.34
    +73.91 (+0.50%)
     
  • Gold

    1,768.10
    -29.80 (-1.66%)
     
  • Crude Oil

    82.66
    +1.35 (+1.66%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • FTSE Bursa Malaysia

    1,598.28
    +5.76 (+0.36%)
     
  • Jakarta Composite Index

    6,633.34
    +7.22 (+0.11%)
     
  • PSE Index

    7,213.46
    +30.35 (+0.42%)
     

Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027

·25-min read

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7. 9 Billion by 2027. - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.

New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neglected Tropical Diseases Diagnosis Industry" - https://www.reportlinker.com/p06032319/?utm_source=GNW
9 Billion by 2027, growing at aCAGR of 4% over the period 2020-2027. Conventional, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$4.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular / Modern segment is readjusted to a revised 4.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.4% CAGR
- The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

- Select Competitors (Total 33 Featured) -

  • Abbott Laboratories

  • Beckman Coulter/Danaher

  • Bio-Rad Laboratories, Inc.

  • Coris Bioconcept SPRL

  • DiaSys Diagnostic Systems GmbH

  • F. Hoffmann-La Roche Ltd.

  • Genome Diagnostics Pvt. Ltd

  • InBios International, Inc.

  • Life Technology

  • Novartis Diagnostics., Ltd.

  • Omega Diagnostics Group PLC

  • Ortho-Clinical Diagnostics

  • Oscar Medicare Pvt Ltd.

  • Premier Medical Corporation Ltd.

  • Siemens Healthcare

  • Thermo Fisher Scientific, Inc.

  • Wako Chemicals, Inc.

  • ZeptoMetrix




Read the full report: https://www.reportlinker.com/p06032319/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Neglected Tropical Diseases
Diagnosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Conventional by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Conventional by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Conventional by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Molecular / Modern
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Molecular / Modern by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Molecular / Modern by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Centralized by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Centralized by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Centralized by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Point of Care by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Point of Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Point of Care by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Clinical Labs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Clinical Labs by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Clinical Labs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Home Healthcare
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Home Healthcare by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Home Healthcare by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 28: USA Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 41: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 42: Canada 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

JAPAN
Table 43: Japan Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 46: Japan Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 50: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

CHINA
Table 52: China Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 53: China Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 54: China 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 55: China Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 58: China Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 59: China Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

EUROPE
Table 61: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 62: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 63: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 64: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 71: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 72: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

FRANCE
Table 73: France Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 74: France Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 75: France 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 76: France Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 79: France Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 80: France Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 81: France 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

GERMANY
Table 82: Germany Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 83: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 84: Germany 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 85: Germany Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 89: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 90: Germany 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

ITALY
Table 91: Italy Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 92: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 93: Italy 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 94: Italy Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 96: Italy 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 98: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 100: UK Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 101: UK Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 102: UK 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 103: UK Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 105: UK 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

SPAIN
Table 109: Spain Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 111: Spain 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 112: Spain Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 113: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 114: Spain 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 115: Spain Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 116: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 117: Spain 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

RUSSIA
Table 118: Russia Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 119: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 120: Russia 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027

Table 121: Russia Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 122: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 123: Russia 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027

Table 124: Russia Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 125: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 126: Russia 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 127: Rest of Europe Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 128: Rest of Europe Historic Review for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 129: Rest of Europe 15-Year Perspective for Neglected
Tropical Diseases Diagnosis by Method - Percentage Breakdown of
Value Sales for Conventional and Molecular / Modern for the
Years 2012, 2020 & 2027

Table 130: Rest of Europe Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 131: Rest of Europe Historic Review for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 132: Rest of Europe 15-Year Perspective for Neglected
Tropical Diseases Diagnosis by Service Type - Percentage
Breakdown of Value Sales for Centralized and Point of Care for
the Years 2012, 2020 & 2027

Table 133: Rest of Europe Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 134: Rest of Europe Historic Review for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 135: Rest of Europe 15-Year Perspective for Neglected
Tropical Diseases Diagnosis by End-Use - Percentage Breakdown

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032319/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting